GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
Rutherford, NJ & Cambridge, UK, April 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and ...
Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...
A new technology has been developed that enables cuffless noninvasive blood pressure monitoring by using ultrasonic to track real-time changes in vascular diameter—without the need for a traditional ...
The EU-funded project IV-Lab aims to develop a multi-sensing device that can be implanted into blood vessels, such as peripheral veins or arteries, to monitor various body parameters and the overall ...
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
Implantable Continuous Blood Glucose Monitor technology could transform lives of patients with diabetes Rutherford, NJ & Cambridge, UK, April 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: ...
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. GlucoTrack’s CBGM is a long-term, implantable system that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results